Marie Rosenthal - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Marie Rosenthal's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Marie Rosenthal
Verified
Senior Editor, Pharmacy Practice News
New York
Beats
anything medical,Local Houston news medical cannabis industry anything technical, Hurricane Harvey recovery
I don't do much hardcore financial and investment reporting.
Content
By Marie Rosenthal Verified| Pharmacy Practice News Verified Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSThe CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the use of meningococcal groups A, B, C, W and Y vaccine (MenABCWY; Penmenvy, GSK) as part of the adolescent meningococcal vaccination schedule to protect against disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y). On Feb.
By Marie Rosenthal Verified| Pharmacy Practice News Verified Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSIn a unanimous vote, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory syncytial virus vaccines to adults 50 to 59 years of age at increased risk for RSV-associated lower respiratory tract disease (LRTD). This includes people with conditions such as chronic obstructive pulmonary disease (COPD), asthma,
By Marie Rosenthal Verified| Pharmacy Practice News Verified Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSThe CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the use of meningococcal groups A, B, C, W and Y vaccine (MenABCWY; Penmenvy, GSK) as part of the adolescent meningococcal vaccination schedule to protect against disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y). On Feb.
Company Info
Pharmacy Practice News
New York, United States